Tsao AS - Search Results

1

Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access program.

Thomas SK, Fossella FV, Liu D, Schaerer R, Tsao AS, Kies MS, Pisters KM, Blumenschein GR Jr, Glisson BS, Lee JJ, Herbst RS, Zinner RG. Thomas SK, et al. Among authors: tsao as. Clin Lung Cancer. 2006 Mar;7(5):326-31. doi: 10.3816/CLC.2006.n.014. Clin Lung Cancer. 2006. PMID: 16640804

2

Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies.

Tsao AS, McDonnell T, Lam S, Putnam JB, Bekele N, Hong WK, Kurie JM. Tsao AS, et al. Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):660-4. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12869408

3

Nonsmall-cell lung cancer: chemoprevention studies.

Karp DD, Tsao AS, Kim ES. Karp DD, et al. Among authors: tsao as. Semin Thorac Cardiovasc Surg. 2003 Oct;15(4):405-20. doi: 10.1053/s1043-0679(03)00100-x. Semin Thorac Cardiovasc Surg. 2003. PMID: 14710383 Review.

4

Phase I evaluation of docetaxel and topotecan for patients with advanced solid tumors.

Tsao AS, Shin DM, Palmer JL, Lee JS, Glisson BS. Tsao AS, et al. Cancer. 2004 May 15;100(10):2240-5. doi: 10.1002/cncr.20238. Cancer. 2004. PMID: 15139070 Free article. Clinical Trial.

5

Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer.

Tsao AS, Liu D, Lee JJ, Spitz M, Hong WK. Tsao AS, et al. Cancer. 2006 Jun 1;106(11):2428-36. doi: 10.1002/cncr.21884. Cancer. 2006. PMID: 16634096 Free article.

6

Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.

Tsao AS, Garden AS, Kies MS, Morrison W, Feng L, Lee JJ, Khuri F, Zinner R, Myers J, Papadimitrakopoulou V, Lewin J, Clayman GL, Ang KK, Glisson BS. Tsao AS, et al. J Clin Oncol. 2006 Sep 1;24(25):4163-9. doi: 10.1200/JCO.2006.05.7851. J Clin Oncol. 2006. PMID: 16943532 Clinical Trial.

7

Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.

Tsao AS, Tang XM, Sabloff B, Xiao L, Shigematsu H, Roth J, Spitz M, Hong WK, Gazdar A, Wistuba I. Tsao AS, et al. J Thorac Oncol. 2006 Mar;1(3):231-9. doi: 10.1016/s1556-0864(15)31573-2. J Thorac Oncol. 2006. PMID: 17409862 Free article.

8

Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion.

Tsao AS, He D, Saigal B, Liu S, Lee JJ, Bakkannagari S, Ordonez NG, Hong WK, Wistuba I, Johnson FM. Tsao AS, et al. Mol Cancer Ther. 2007 Jul;6(7):1962-72. doi: 10.1158/1535-7163.MCT-07-0052. Mol Cancer Ther. 2007. PMID: 17620427

9

Neoadjuvant and intrapleural therapies for malignant pleural mesothelioma.

Tsao AS, Mehran R, Roth JA. Tsao AS, et al. Clin Lung Cancer. 2009 Jan;10(1):36-41. doi: 10.3816/CLC.2009.n.005. Clin Lung Cancer. 2009. PMID: 19289370 Review.

10

Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.

Tsao AS, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK, Wistuba I, Culotta KS, Mao L, Gillenwater A, Sagesaka YM, Hong WK, Papadimitrakopoulou V. Tsao AS, et al. Cancer Prev Res (Phila). 2009 Nov;2(11):931-41. doi: 10.1158/1940-6207.CAPR-09-0121. Cancer Prev Res (Phila). 2009. PMID: 19892663 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters